[Federal Register Volume 63, Number 76 (Tuesday, April 21, 1998)]
[Notices]
[Pages 19737-19738]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10438]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Child Health and Human Development Special 
Emphasis Panel (SEP) meeting:

    Name of SEP: In Vivo and In Vitro Evaluation of Terbinafine as a 
CYP2D6 Inhibitor (TELECONFERENCE).
    Date: April 23, 1998.
    Time: 10:30 p.m.--adjournment.
    Place: 6100 Executive Boulevard, 6100 Building, Room 5E01, 
Rockville, Maryland 20852.
    Contact Person: Gopal Bhatnagar, Ph.D., Scientific Review 
Administrator, NICHD, 6100 Executive Boulevard, Room 5E01, 
Rockville, MD 20852, Telephone: 301-496-1485.
    Purpose/Agenda: To evaluate and review research grant 
applications.
    This meeting will be closed in accordance with the provisions 
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The 
discussion of these applications could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with these 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

(Catalog of Federal Domestic Assistance Program Nos. [93.864, 
Population Research and No. 93.865, Research for Mothers and 
Children], National Institute of Health, HHS)


[[Page 19738]]


    Dated: April 14, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-10438 Filed 4-20-98; 8:45 am]
BILLING CODE 4140-01-M